Insurers: Medicare drug regulations could drive up costs

Medicare Advantage and Medicare drug plan insurers told the Centers for Medicaid and Medicare Services that too much regulation at once could drive up costs and result in increased premiums or fewer benefits, Axios reports. The public comment closed this week on a proposal to crack down on Medicare Advantage marketing practices, impose other standards on Medicare drug plans and create requirements to increase access to behavioral health and culturally competent care.